• Gastrin I: Designing Better Organoid Assays

  2026-09-03

  Gastrin I is more than a stimulus for gastric acid secretion: it can serve as a mechanistic perturbation for testing receptor competence, epithelial polarity, and assay validity. This guide connects the human Gastrin I peptide with new hiPSC-derived organoid methods while clearly defining their translational limits.

• Lactate–GPR81–RAC1 Control of Glucose Uptake

  2026-09-03

  A 2026 Cell Research study identifies lactate as an insulin-independent regulator of skeletal-muscle glucose uptake. Its central finding is that lactate activates GPR81, recruits FARP1, and stimulates RAC1-dependent GLUT4 translocation, linking exercise-associated metabolism to glucose control.

• Microfluidized Microgels for Oral Colon Cancer Therapy

  2026-09-02

  The reference study developed dextran microgels that sequentially deliver cisplatin- and SPION-loaded lipid nanoparticles to orthotopic colon tumors after oral administration. Colon-associated enzymatic release, dextran-mediated retention, folate-receptor targeting, chemotherapy, and magnetothermal treatment were integrated to improve local efficacy while limiting nonspecific gastrointestinal exposure.

• MitMAB for Reproducible Endocytosis Assays

  2026-09-02

  This scenario-based guide explains how MitMAB (SKU B7620) can help researchers separate dynamin-dependent vesicle uptake from nonspecific changes in cell viability, especially in intestinal organoid and extracellular-vesicle workflows. It covers model compatibility, solution handling, controls, interpretation, and practical supplier-selection criteria.

• PD 173074 for FGFR1/VEGFR2 Research

  2026-09-01

  PD 173074 enables controlled interrogation of FGFR1 and VEGFR2 signaling across pancreatic cancer, angiogenesis, and drug-resistance models. This practical guide connects the compound to a pancreatic adenocarcinoma systems study while emphasizing assay design, exposure control, and interpretation limits.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-09-01

  Build a reproducible DNA fragmentation assay for cultured cells, frozen tissue, and paraffin sections with practical TdT-labeling controls. Learn how to pair Cy3 TUNEL imaging or flow cytometry with oncology workflows, including colorectal cancer treatment-response studies.

• Iptacopan Workflows for Complement Research

  2026-08-31

  Iptacopan (LNP023) enables selective alternative-pathway interrogation across serum, red-cell, and disease-model workflows. Its reversible factor B mechanism connects biochemical C3bBb inhibition with translational readouts such as C3 deposition, membrane attack complex formation, and hemolysis.

• Iptacopan (LNP023) Complement Research Workflows

  2026-08-31

  Build selective alternative-pathway experiments around Iptacopan, from factor B enzyme inhibition to serum MAC formation, C3 deposition, and complement-mediated hemolysis. The workflow emphasizes concentration-response design, pathway-specific controls, donor and species effects, and translation to complement-mediated disease models.

• Dabigatran in Thromboembolic Disorder Prevention

  2026-08-30

  The 2015 review by Enriquez and colleagues positioned Dabigatran as the first widely introduced non-vitamin K oral anticoagulant directed against thrombin, integrating its mechanism, pharmacokinetics, trial evidence, and safety considerations. Its findings support predictable fixed-dose anticoagulation across atrial fibrillation, venous thromboembolism, and orthopedic prophylaxis, while emphasizing renal clearance and bleeding management as important boundaries.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-08-29

  Liu and colleagues developed carrier-platin, a polymer-confined platinum nanotherapeutic that rapidly generates intracellular reactive oxygen species and kills cancer cells independently of conventional DNA damage. The study suggests that catalytic redox activity, rather than platinum–DNA binding alone, can provide a distinct strategy for treating drug-resistant tumors while highlighting important questions about mechanism, delivery, and translational safety.

• GDC-0941 Workflows for PI3K/Akt Research

  2026-08-28

  Build reproducible PI3K/Akt pathway inhibition experiments with GDC-0941, from pAKT suppression and viability testing to resistance-model analysis. This practical guide connects pathway pharmacology with the DRD4–Akt–β-catenin mechanism implicated in liver cancer stem-cell phenotypes.

• Iptacopan (LNP023): Factor B Inhibition

  2026-08-28

  Iptacopan (LNP023) is an oral, selective complement factor B inhibitor that blocks alternative-pathway amplification. In a phase II PNH study, monotherapy rapidly reduced hemolysis and improved hemoglobin and transfusion outcomes. Its assay profile supports complement activation research from C3bBb inhibition to disease-model evaluation.

• Murine RNase Inhibitor for RNA Integrity

  2026-08-27

  Murine RNase Inhibitor provides targeted protection against pancreatic-type RNases in RT-PCR, cDNA synthesis, transcription, and RNA-labeling workflows. Its oxidation-resistant design is especially useful when reactions require low DTT, while its defined specificity helps researchers avoid masking unrelated nuclease activities.

• Gemini Quaternary Ammonium Compounds: 2024 Findings

  2026-08-27

  The reference study synthesized 16 novel gemini quaternary ammonium compounds and identified candidates with activity across bacteria, biofilms, fungi, and viruses. Its structure–activity analysis links polarity, membrane-related behavior, antimicrobial breadth, and cytotoxicity, offering a framework for evaluating alternatives to octenidine and benzalkonium chloride.

• Deferoxamine Mesylate in Ferroptosis Workflows

  2026-08-26

  Deferoxamine mesylate gives researchers a practical way to control labile iron while probing ferroptosis, oxidative stress, and HIF-1α stabilization. This guide connects iron chelation to resistant colorectal cancer assays, wound healing promotion, and tissue-protection workflows, with actionable setup and troubleshooting advice.

8602 records 2/574 page Previous Next 12345 下5页 Last page